血脂康治疗2型糖尿病合并血脂异常的临床观察

Clinical Observation on Type 2 Diabetes With Dyslipidemia Xuezhikang

目的观察血脂康治疗2型糖尿病合并血脂异常的临床疗效及安全性。方法选择2012年5月-2014年4月在天津市红桥区咸阳北路街社区卫生服务中心门诊就诊的2型糖尿病合并血脂异常的患者65例,所有患者随机分为治疗组和对照组两组,对照组33例,给予安慰剂治疗;治疗组32例,治疗组在对照组的基础上加用血脂康胶囊口服,疗程为2个月,之后进行疗效评价。结果治疗组患者的甘油三酯（TG）、总胆固醇（TC）、低密度脂蛋白（LDL）、高密度脂蛋白（HDL）改善均优于对照组。结论血脂康治疗2型糖尿病合并血脂异常疗效确切安全。

Objective To observe the effect of Xuezhikang in treatment of type 2 diabetes clinical curative effect and safety of combined dyslipidemia. Methods 2012 May-2014 year in April 65 cases in our hospital out-patient treatment of type 2 diabetes with dyslipidemia patients, all patients were randomly divided into treatment group and control group two groups, 33 cases in the control group, received a placebo, 32 cases in the treatment group, the treatment group with Xuezhikang Capsule on the basis of control group, treatment for 2 months, after the evaluation of curative effect. Results The patients in the treatment group were triglyceride（TG）, total cholesterol（TC）, low density lipoprotein（LDL）, high density lipoprotein（HDL） were better than the control group. Conclusion Xuezhikang in treatment of patients with type 2 diabetic dyslipidemia and safe.